History

 

 

Altan Pharma LTD. is a specialty pharmaceutical company that develops, manufactures and markets injectable medications for the hospital and other provider segments. The company was founded with the strategic objective of building a premier, global injectable drug company that is committed to improving patient care by providing specialty medications of superior quality and value for the benefit of patients and caregivers. 

Altan will establish and grow its business by acquiring and developing attractive products and assets; adding value through systematic implementation of best practices in manufacturing, distribution, regulatory, R&D and commercial operations; and, consolidating those assets into an integrated and highly efficient global organization.

On June 10, 2015 Altan made its first acquisition, a manufacturer of injectable drugs headquartered in Madrid Spain: The GES Group. GES develops, manufactures and sells specialty injectable products in Spain and exports products to distribution partners in other European countries as well as Latin America, Asia and other regional markets.

 

Altan intends to build on the GES acquisition and will invest significant resources to deliver organic and inorganic growth through expansion of international partnerships, targeted product development and acquisition of complimentary product lines and assets.

Altan intends to build on the GES acquisition and will invest significant resources to deliver organic and inorganic growth through expansion of international partnerships, targeted product development and acquisition of complimentary product lines and assets.

From January 1, 2019, as part of the integration of the group companies, Altan Pharmaceuticals, S.A.U( previously known as GES Genéricos Españoles Laboratorio, S.A.U), which is the Spanish affiliate.

 

Altan has their own I+D department with provent experience in development of innovative generics and conducting clinical studies, for example the develpment of the first ready to use formulations of Paracetamol and Ibuprofen that are available in bags IV.

Altan  will establish and grow its business through the acquisition and development of attractive products, adding value through the systematic application of pracrices in manufacturing, distribution, regulation, research and development and operations; and, the consolidation of the assets in a integrated and highly efficient global organization.